Product Description
The global hyaluronic acid viscosupplementation market was valued at $2.5 billion in 2024. This is expected to increase over the forecast period at a CAGR of 2.9% to reach $3 billion.
The full report suite on the global market for hyaluronic acid (HA) viscosupplementation includes single injection, two injections, three injections and five injections.
This report includes data for 65 countries across 7 different regions. These regions are North America, Latin America, Western Europe, Central & Eastern Europe, Middle East, Asia-Pacific, and Africa.
DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers
- Market Drivers & Limiters
- Market Forecasts Until 2031, and Historical Data to 2021
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
GLOBAL HYALURONIC ACID VISCOSUPPLEMENTATION MARKET INSIGHTS
The HA viscosupplementation market experienced a notable decline in sales due to the COVID-19 pandemic. The primary driver was the widespread cancellation and postponement of elective surgeries, which significantly disrupted the industry’s ecosystem. While this downturn was temporary, the impact in 2020 was substantial, with many companies incurring unprecedented losses. However, the market demonstrated resilience and managed to recover notably by 2022, returning to its trajectory of steady growth.
GLOBAL HYALURONIC ACID VISCOSUPPLEMENTATION MARKET SHARE INSIGHTS
- DePuy Synthes was the leader of the HA viscosupplementation market due to the success of both MONOVISC® single-injection and ORTHOVISC® three-injection products.
- Fidia held the second-leading position in the HA viscosupplementation market by offering its two-injection product HYMOVIS®.
- Sanofi was the third-leading competitor in the HA viscosupplementation market in 2024. The company competes with its products Synvisc® and Synvisc-One®, benefiting from the rising cases of osteoarthritis and an aging population.
GLOBAL HYALURONIC ACID VISCOSUPPLEMENTATION MARKET SEGMENTATION SUMMARY
- Single Injection Market
- Two Injections Market
- Three Injections Market
- Five Injections Market
RESEARCH SCOPE SUMMARY
Report Attribute | Details |
---|---|
Regions | North America(Canada, United States) Latin America(Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela) Western Europe(Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom) Central & Eastern Europe(Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine) Middle East(Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific(Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam) Africa(Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
Base Year | 2024 |
Forecast | 2025-2031 |
Historical Data | 2021-2023 |
Quantitative Coverage | Procedure Numbers, Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
Qualitative Coverage | COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |